These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 31450608

  • 1. Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.
    Zhou L, Zou M, Zhu K, Ning S, Xia X.
    Molecules; 2019 Aug 24; 24(17):. PubMed ID: 31450608
    [Abstract] [Full Text] [Related]

  • 2. Use of different ligand modification liposomes to evaluate the anti-liver tumor activity of cantharidin.
    Zou M, Xu Y, Lin P, Zhou L, Xia X.
    J Liposome Res; 2023 Sep 24; 33(3):283-299. PubMed ID: 36594207
    [Abstract] [Full Text] [Related]

  • 3. 18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Antitumor Effects, and Liver-Targeting Efficiency.
    Zhu K, Zhou L, Zou M, Ning S, Liu S, Zhou Y, Du K, Zhang X, Xia X.
    J Pharm Sci; 2020 Jun 24; 109(6):2038-2047. PubMed ID: 32173319
    [Abstract] [Full Text] [Related]

  • 4. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
    Xu Y, Wang M, Ning S, Yang Z, Zhou L, Xia X.
    Molecules; 2022 Oct 11; 27(20):. PubMed ID: 36296377
    [Abstract] [Full Text] [Related]

  • 5. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
    Li J, Xu H, Ke X, Tian J.
    J Drug Target; 2012 Jun 11; 20(5):467-73. PubMed ID: 22577855
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma.
    Zhang X, Lin C, Lu A, Lin G, Chen H, Liu Q, Yang Z, Zhang H.
    Drug Deliv; 2017 Nov 11; 24(1):986-998. PubMed ID: 28644728
    [Abstract] [Full Text] [Related]

  • 10. Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study.
    Sun S, Shang E, Ju A, Li Y, Wu Q, Li Q, Yang Y, Guo Y, Yang D, Lv S.
    Fitoterapia; 2021 Nov 11; 155():105033. PubMed ID: 34517057
    [Abstract] [Full Text] [Related]

  • 11. Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma.
    Xu N, Wu J, Wang W, Sun S, Sun M, Bian Y, Zhang H, Liu S, Yu G.
    Drug Deliv Transl Res; 2024 Sep 11; 14(9):2386-2402. PubMed ID: 38236508
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L, Liang L, Guo M, Li M, Yu X, Wang Y, Wang Y.
    Curr Top Med Chem; 2021 Oct 05; 21(14):1268-1284. PubMed ID: 34620053
    [Abstract] [Full Text] [Related]

  • 14. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
    Qiu M, Wang J, Bai J, Li X, Tian C, Liu Z, Zheng C, Clark AR, Cheng X, Liao X, Wu S, Lee RJ, Zhou X.
    Mol Pharm; 2023 Apr 03; 20(4):1951-1963. PubMed ID: 36952242
    [Abstract] [Full Text] [Related]

  • 15. Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis.
    Qi C, Wang D, Gong X, Zhou Q, Yue X, Li C, Li Z, Tian G, Zhang B, Wang Q, Wei X, Wu J.
    ACS Appl Mater Interfaces; 2021 Apr 14; 13(14):16019-16035. PubMed ID: 33819006
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.